Evidence map›Paper›PMID 33963862›Full record

ArticleNucleic acids research2021

A structural intermediate pre-organizes the add adenine riboswitch for ligand recognition.

Patrick St-Pierre, Euan Shaw, Samuel Jacques, Paul A Dalgarno, Cibran Perez-Gonzalez, Frédéric Picard-Jean, J Carlos Penedo, Daniel A Lafontaine

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Exploring functional transitions of the 2'-dG riboswitch aptamer.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Thoughts on how to think (and talk) about RNA structure.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Patrick St-PierreDepartment of Biology, Faculty of Science, Université de Sherbrooke, Sherbrooke, Quebec J1K 2R1, Canada.
Euan ShawCentre of Biophotonics, School of Physics and Astronomy, University of St Andrews, St Andrews, Fife, KY16 9SS, UK.
Samuel JacquesDepartment of Biology, Faculty of Science, Université de Sherbrooke, Sherbrooke, Quebec J1K 2R1, Canada.
Paul A DalgarnoCentre of Biophotonics, School of Physics and Astronomy, University of St Andrews, St Andrews, Fife, KY16 9SS, UK.
Cibran Perez-GonzalezBiomedical Sciences Research Complex, University of St Andrews, St Andrews, Fife, KY16 9SS, UK.
Frédéric Picard-JeanDepartment of Biology, Faculty of Science, Université de Sherbrooke, Sherbrooke, Quebec J1K 2R1, Canada.
J Carlos PenedoCentre of Biophotonics, School of Physics and Astronomy, University of St Andrews, St Andrews, Fife, KY16 9SS, UK.ORCID 0000-0002-5807-5385
Daniel A LafontaineDepartment of Biology, Faculty of Science, Université de Sherbrooke, Sherbrooke, Quebec J1K 2R1, Canada.ORCID 0000-0001-7891-5700
Université de Sherbrooke · CAUniversity of St Andrews · GB

Funding

CIHR
6 · The paper itself

Abstract

Riboswitches are RNA sequences that regulate gene expression by undergoing structural changes upon the specific binding of cellular metabolites. Crystal structures of purine-sensing riboswitches have revealed an intricate network of interactions surrounding the ligand in the bound complex. The mechanistic details about how the aptamer folding pathway is involved in the formation of the metabolite binding site have been previously shown to be highly important for the riboswitch regulatory activity. Here, a combination of single-molecule FRET and SHAPE assays have been used to characterize the folding pathway of the adenine riboswitch from Vibrio vulnificus. Experimental evidences suggest a folding process characterized by the presence of a structural intermediate involved in ligand recognition. This intermediate state acts as an open conformation to ensure ligand accessibility to the aptamer and folds into a structure nearly identical to the ligand-bound complex through a series of structural changes. This study demonstrates that the add riboswitch relies on the folding of a structural intermediate that pre-organizes the aptamer global structure and the ligand binding site to allow efficient metabolite sensing and riboswitch genetic regulation.

Indexed as

AdenineAptamers, NucleotideBinding SitesLigandsModels, MolecularMutationNucleic Acid ConformationRiboswitchRNA FoldingSingle Molecule ImagingSoftwareSpectroscopy, Fourier Transform InfraredVibrio vulnificusAdenineAptamers, NucleotideLigandsRiboswitch

Identifiers

PMID33963862
PMCPMC8191784
OpenAlexW3157491280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.